Vendor profile Research · US · —

Wuhan Wansheng Biotechnology

B+
Composite 7.6 / 10

Last updated 2026-10-12. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
6.0
Fair
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
9.5
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
GHK-Cu
9.2A
9.0 23 — — — — view
Retatrutide
8.9B+
8.6 77 — — — — view
Tirzepatide
8.7B+
8.6 53 — — — — view
Semaglutide
7.3B
6.6 5 — — — — view
Ipamorelin
7.2B
6.5 15 — — — — view
PT-141
6.1C
6.1 4 — — — — view
BPC-157
5.4C
4.3 20 — — — — view
TB-500
5.1C
3.9 10 — — — — view
Tesamorelin
4.5D
3.2 27 — — — — view
CJC-1295
4.3D
2.9 7 — — — — view
KPV
—
— 0 — — — — view
Epitalon
—
— 0 — — — — view
Sermorelin
—
— 0 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Wuhan Wansheng Biotechnology against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.